newsfilter
← Latest News
GlobeNewswire·

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients